Ipatasertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
The global Ipatasertib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ipatasertib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ipatasertib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ipatasertib include Abcam, Cayman Chemical, Selleck Chemicals, BOC Sciences, BioVision, Adooq Bioscience, Focus Biomolecules, Biorbyt and AbMole, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ipatasertib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ipatasertib.
Report Scope
The Ipatasertib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ipatasertib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ipatasertib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Cayman Chemical
Selleck Chemicals
BOC Sciences
BioVision
Adooq Bioscience
Focus Biomolecules
Biorbyt
AbMole
LifeSpan BioSciences
MyBiosource
LGC
MuseChem
Shimadzu
Taiclone
Aladdin
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
Taiwan,China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ipatasertib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ipatasertib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ipatasertib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Ipatasertib Market Overview
1.1 Product Definition
1.2 Ipatasertib Segment by Type
1.2.1 Global Ipatasertib Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Ipatasertib Segment by Application
1.3.1 Global Ipatasertib Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Ipatasertib Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ipatasertib Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ipatasertib Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ipatasertib Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ipatasertib Production Market Share by Manufacturers (2019-2024)
2.2 Global Ipatasertib Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ipatasertib, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ipatasertib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ipatasertib Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ipatasertib, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ipatasertib, Product Offered and Application
2.8 Global Key Manufacturers of Ipatasertib, Date of Enter into This Industry
2.9 Ipatasertib Market Competitive Situation and Trends
2.9.1 Ipatasertib Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ipatasertib Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ipatasertib Production by Region
3.1 Global Ipatasertib Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ipatasertib Production Value by Region (2019-2030)
3.2.1 Global Ipatasertib Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ipatasertib by Region (2025-2030)
3.3 Global Ipatasertib Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ipatasertib Production by Region (2019-2030)
3.4.1 Global Ipatasertib Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ipatasertib by Region (2025-2030)
3.5 Global Ipatasertib Market Price Analysis by Region (2019-2024)
3.6 Global Ipatasertib Production and Value, Year-over-Year Growth
3.6.1 North America Ipatasertib Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ipatasertib Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ipatasertib Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ipatasertib Production Value Estimates and Forecasts (2019-2030)
3.6.5 Taiwan,China Ipatasertib Production Value Estimates and Forecasts (2019-2030)
4 Ipatasertib Consumption by Region
4.1 Global Ipatasertib Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ipatasertib Consumption by Region (2019-2030)
4.2.1 Global Ipatasertib Consumption by Region (2019-2024)
4.2.2 Global Ipatasertib Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ipatasertib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ipatasertib Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ipatasertib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ipatasertib Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ipatasertib Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ipatasertib Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ipatasertib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ipatasertib Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ipatasertib Production by Type (2019-2030)
5.1.1 Global Ipatasertib Production by Type (2019-2024)
5.1.2 Global Ipatasertib Production by Type (2025-2030)
5.1.3 Global Ipatasertib Production Market Share by Type (2019-2030)
5.2 Global Ipatasertib Production Value by Type (2019-2030)
5.2.1 Global Ipatasertib Production Value by Type (2019-2024)
5.2.2 Global Ipatasertib Production Value by Type (2025-2030)
5.2.3 Global Ipatasertib Production Value Market Share by Type (2019-2030)
5.3 Global Ipatasertib Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ipatasertib Production by Application (2019-2030)
6.1.1 Global Ipatasertib Production by Application (2019-2024)
6.1.2 Global Ipatasertib Production by Application (2025-2030)
6.1.3 Global Ipatasertib Production Market Share by Application (2019-2030)
6.2 Global Ipatasertib Production Value by Application (2019-2030)
6.2.1 Global Ipatasertib Production Value by Application (2019-2024)
6.2.2 Global Ipatasertib Production Value by Application (2025-2030)
6.2.3 Global Ipatasertib Production Value Market Share by Application (2019-2030)
6.3 Global Ipatasertib Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Abcam
7.1.1 Abcam Ipatasertib Corporation Information
7.1.2 Abcam Ipatasertib Product Portfolio
7.1.3 Abcam Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Abcam Main Business and Markets Served
7.1.5 Abcam Recent Developments/Updates
7.2 Cayman Chemical
7.2.1 Cayman Chemical Ipatasertib Corporation Information
7.2.2 Cayman Chemical Ipatasertib Product Portfolio
7.2.3 Cayman Chemical Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Cayman Chemical Main Business and Markets Served
7.2.5 Cayman Chemical Recent Developments/Updates
7.3 Selleck Chemicals
7.3.1 Selleck Chemicals Ipatasertib Corporation Information
7.3.2 Selleck Chemicals Ipatasertib Product Portfolio
7.3.3 Selleck Chemicals Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Selleck Chemicals Main Business and Markets Served
7.3.5 Selleck Chemicals Recent Developments/Updates
7.4 BOC Sciences
7.4.1 BOC Sciences Ipatasertib Corporation Information
7.4.2 BOC Sciences Ipatasertib Product Portfolio
7.4.3 BOC Sciences Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.4.4 BOC Sciences Main Business and Markets Served
7.4.5 BOC Sciences Recent Developments/Updates
7.5 BioVision
7.5.1 BioVision Ipatasertib Corporation Information
7.5.2 BioVision Ipatasertib Product Portfolio
7.5.3 BioVision Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.5.4 BioVision Main Business and Markets Served
7.5.5 BioVision Recent Developments/Updates
7.6 Adooq Bioscience
7.6.1 Adooq Bioscience Ipatasertib Corporation Information
7.6.2 Adooq Bioscience Ipatasertib Product Portfolio
7.6.3 Adooq Bioscience Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Adooq Bioscience Main Business and Markets Served
7.6.5 Adooq Bioscience Recent Developments/Updates
7.7 Focus Biomolecules
7.7.1 Focus Biomolecules Ipatasertib Corporation Information
7.7.2 Focus Biomolecules Ipatasertib Product Portfolio
7.7.3 Focus Biomolecules Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Focus Biomolecules Main Business and Markets Served
7.7.5 Focus Biomolecules Recent Developments/Updates
7.8 Biorbyt
7.8.1 Biorbyt Ipatasertib Corporation Information
7.8.2 Biorbyt Ipatasertib Product Portfolio
7.8.3 Biorbyt Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Biorbyt Main Business and Markets Served
7.7.5 Biorbyt Recent Developments/Updates
7.9 AbMole
7.9.1 AbMole Ipatasertib Corporation Information
7.9.2 AbMole Ipatasertib Product Portfolio
7.9.3 AbMole Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.9.4 AbMole Main Business and Markets Served
7.9.5 AbMole Recent Developments/Updates
7.10 LifeSpan BioSciences
7.10.1 LifeSpan BioSciences Ipatasertib Corporation Information
7.10.2 LifeSpan BioSciences Ipatasertib Product Portfolio
7.10.3 LifeSpan BioSciences Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.10.4 LifeSpan BioSciences Main Business and Markets Served
7.10.5 LifeSpan BioSciences Recent Developments/Updates
7.11 MyBiosource
7.11.1 MyBiosource Ipatasertib Corporation Information
7.11.2 MyBiosource Ipatasertib Product Portfolio
7.11.3 MyBiosource Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.11.4 MyBiosource Main Business and Markets Served
7.11.5 MyBiosource Recent Developments/Updates
7.12 LGC
7.12.1 LGC Ipatasertib Corporation Information
7.12.2 LGC Ipatasertib Product Portfolio
7.12.3 LGC Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.12.4 LGC Main Business and Markets Served
7.12.5 LGC Recent Developments/Updates
7.13 MuseChem
7.13.1 MuseChem Ipatasertib Corporation Information
7.13.2 MuseChem Ipatasertib Product Portfolio
7.13.3 MuseChem Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.13.4 MuseChem Main Business and Markets Served
7.13.5 MuseChem Recent Developments/Updates
7.14 Shimadzu
7.14.1 Shimadzu Ipatasertib Corporation Information
7.14.2 Shimadzu Ipatasertib Product Portfolio
7.14.3 Shimadzu Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Shimadzu Main Business and Markets Served
7.14.5 Shimadzu Recent Developments/Updates
7.15 Taiclone
7.15.1 Taiclone Ipatasertib Corporation Information
7.15.2 Taiclone Ipatasertib Product Portfolio
7.15.3 Taiclone Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Taiclone Main Business and Markets Served
7.15.5 Taiclone Recent Developments/Updates
7.16 Aladdin
7.16.1 Aladdin Ipatasertib Corporation Information
7.16.2 Aladdin Ipatasertib Product Portfolio
7.16.3 Aladdin Ipatasertib Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Aladdin Main Business and Markets Served
7.16.5 Aladdin Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ipatasertib Industry Chain Analysis
8.2 Ipatasertib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ipatasertib Production Mode & Process
8.4 Ipatasertib Sales and Marketing
8.4.1 Ipatasertib Sales Channels
8.4.2 Ipatasertib Distributors
8.5 Ipatasertib Customers
9 Ipatasertib Market Dynamics
9.1 Ipatasertib Industry Trends
9.2 Ipatasertib Market Drivers
9.3 Ipatasertib Market Challenges
9.4 Ipatasertib Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Abcam
Cayman Chemical
Selleck Chemicals
BOC Sciences
BioVision
Adooq Bioscience
Focus Biomolecules
Biorbyt
AbMole
LifeSpan BioSciences
MyBiosource
LGC
MuseChem
Shimadzu
Taiclone
Aladdin
*If Applicable.